JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma

Carcinogenesis

Volumn 34, Issue 12, 2013, Pages 2778-2788

  Lu, Jing ^a,b   Tang, Yun ^a   Farshidpour, Maham ^a   Cheng, Yabin ^a   Zhang, Guohong ^a,c   Jafarnejad, Seyed Mehdi ^a   Yip, Alan ^a   Martinka, Magdalena ^a   Dong, Ziming ^b   Zhou, Jianwei ^d   Xu, Jinhua ^e   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ZHENGZHOU UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTEGRIN LINKED KINASE; JWA PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA CELL; METASTATIC MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR BIOPSY; TUMOR GROWTH;

CELL LINE, TUMOR; CELLS, CULTURED; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HEAT-SHOCK PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOGLOBULINS; INTEGRIN ALPHAVBETA3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84889039757     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt318     Document Type: Article

References (49)

1. Siegel,R. et al. (2013) Cancer statistics, 2013. CA. Cancer J. Clin., 63, 11-30.
2. Houghton,A.N. et al. (2002) Focus on melanoma. Cancer Cell, 2, 275-278.
3. Balch,C.M. et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol., 19, 3635-3648.
4. Trinh,V.A. (2008) Current management of metastatic melanoma. Am. J. Health. Syst. Pharm., 65 (suppl. 9), S3-S8.
5. Árquez-Rodas,I. et al. (2011) A new era in the treatment of melanoma: from biology to clinical practice. Clin. Transl. Oncol., 13, 787-792.
6. Qin,L. et al. (2012) Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed. Adv. Cancer Res., 113, 191-239.
7. Weis,S.M. et al. (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med., 17, 1359-1370.
8. Zhou,J.W. et al. (1999) Investigation on Cell Modulation: Signal Transduction, Apoptosis and Gene Expression. Military Medical Sciences Press, Beijing, pp. 110-119.
9. Butchbach,M.E. et al. (2002) Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene, 292, 81-90.
10. Schweneker,M. et al. (2005) JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett., 579, 1751-1758.
11. Chen,H. et al. (2007) JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell. Signal, 19, 1315-1327.
12. Bai,J. et al. (2010) JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling. Oncogene, 29, 1227-1237.
13. Rathinam,R. et al. (2010) Important role of integrins in the cancer biology. Cancer Metastasis Rev., 29, 223-237.
14. Hannigan,G. et al. (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat. Rev. Cancer, 5, 51-63.
15. Legate,K.R. et al. (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell Biol., 7, 20-31.
16. McDonald,P.C. et al. (2008) Integrin-linked kinase-essential roles in physiology and cancer biology. J. Cell Sci., 121(Pt 19), 3121-3132.
17. Takanami,I. (2005) Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer. BMC Cancer, 5, 1.
18. Graff,J.R. et al. (2001) Integrin-linked kinase expression increases with prostate tumor grade. Clin. Cancer Res., 7, 1987-1991.
19. Dai,D.L. et al. (2003) Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin. Cancer Res., 9, 4409-4414.
20. Wani,A.A. et al. (2011) Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway. Oncogene, 30, 2778-2788.
21. Melchior,C. et al. (2002) Promoter characterization and genomic organization of the gene encoding integrin-linked kinase 1. Biochim. Biophys. Acta, 1575, 117-122.
22. Lössner,D. et al. (2009) Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. J. Cell. Physiol., 220, 367-375.
23. Karst,A.M. et al. (2009) Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int. J. Cancer, 124, 494-501.
24. Li,J. et al. (2010) Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1. Cancer Res., 70, 10445-10453.
25. Jafarnejad,S.M. et al. (2010) Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am. J. Pathol., 177, 2741-2752.
26. Wong,R.P. et al. (2007) The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol. Cancer Ther., 6, 1692-1700.
27. Folkman,J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285, 1182-1186.
28. Mahabeleshwar,G.H. et al. (2007) Angiogenesis in melanoma. Semin. Oncol., 34, 555-565.
29. Kok,K. et al. (1997) Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res., 71, 27-92.
30. Pontier,S.M. et al. (2010) Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene, 29, 3374-3385.
31. Tan,C. et al. (2004) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell, 5, 79-90.
32. Brooks,P.C. et al. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science, 264, 569-571.
33. Brooks,P.C. et al. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157-1164.
34. Gladson,C.L. et al. (1991) Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J. Clin. Invest., 88, 1924-1932.
35. Desgrosellier,J.S. et al. (2009) An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med., 15, 1163-1169.
36. Safe,S. et al. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer, 41, 2438-2448.
37. Wang,L. et al. (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin. Cancer Res., 9, 6371-6380.
38. Xie,J. et al. (2011) The impairment of ILK related angiogenesis involved in cardiac maladaptation after infarction. PLoS One, 6, e24115.
39. Friedrich,E.B. et al. (2004) Integrin-linked kinase regulates endothelial cell survival and vascular development. Mol. Cell. Biol., 24, 8134-8144.
40. Janji,B. et al. (2000) Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation. Oncogene, 19, 3069-3077.
41. Gao,K. et al. (2006) Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration. Cancer Res., 66, 8382-8388.
42. Lázár-Molnár,E. et al. (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 12, 547-554.
43. Wei,L.H. et al. (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene, 22, 1517-1527.
44. Huang,S.P. et al. (2004) Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J. Biomed. Sci., 11, 517-527.
45. Saidi,A. et al. (2009) Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int. J. Cancer, 125, 1054-1064.
46. Jemal,A. et al. (2008) Cancer statistics, 2008. CA. Cancer J. Clin., 58, 71-96.
47. Liang,C.H. et al. (2013) a-Catulin drives metastasis by activating ILK and driving an avß3 integrin signaling axis. Cancer Res., 73, 428-438.
48. Muranyi,A.L. et al. (2009) Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells. Exp. Hematol., 37, 450-460.
49. Cox,D. et al. (2010) Integrins as therapeutic targets: lessons and opportunities. Nat. Rev. Drug Discov., 9, 804-820.